146 related articles for article (PubMed ID: 36316812)
21. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
Lin Q; Chen H; Zhang M; Xiong H; Jiang Q
Biomed Pharmacother; 2019 Jul; 115():108939. PubMed ID: 31079003
[TBL] [Abstract][Full Text] [Related]
22. Long Noncoding RNA HOTAIR Promotes Endometrial Carcinoma Cell Proliferation by Binding to PTEN via the Activating Phosphatidylinositol 3-Kinase/Akt Signaling Pathway.
Zhang XH; Hu P; Xie YQ; Kang YJ; Li M
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31527078
[TBL] [Abstract][Full Text] [Related]
23. HOTTIP regulates progression of endometrial cancer via activating PI3K/AKT pathway.
Guan Q; Zhang Q; Zhang C; Liu Q; Ren QL
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3727-3733. PubMed ID: 29949146
[TBL] [Abstract][Full Text] [Related]
24. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
25. Pentamidine inhibits proliferation, migration and invasion in endometrial cancer via the PI3K/AKT signaling pathway.
Lin L; Gao Y; Hu X; Ouyang J; Liu C
BMC Womens Health; 2022 Nov; 22(1):470. PubMed ID: 36434592
[TBL] [Abstract][Full Text] [Related]
26. LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway.
Li Z; Jin Q; Sun Y
J Clin Lab Anal; 2022 Jul; 36(7):e24406. PubMed ID: 35588431
[TBL] [Abstract][Full Text] [Related]
27. Williams syndrome transcription factor promotes proliferation and invasion of cervical cancer cells by regulating PI3K/Akt signaling pathway.
Jiang D; Ren C; Yang L; Li F; Yang X; Zheng Y; Ji X; Tian Y
J Obstet Gynaecol Res; 2021 Jul; 47(7):2433-2441. PubMed ID: 34028125
[TBL] [Abstract][Full Text] [Related]
28. HDAC6, modulated by miR-206, promotes endometrial cancer progression through the PTEN/AKT/mTOR pathway.
Zheng Y; Yang X; Wang C; Zhang S; Wang Z; Li M; Wang Y; Wang X; Yang X
Sci Rep; 2020 Feb; 10(1):3576. PubMed ID: 32107418
[TBL] [Abstract][Full Text] [Related]
29. Knockdown of otubain 2 inhibits liver cancer cell growth by suppressing NF-κB signaling.
Gu ZL; Huang J; Zhen LL
Kaohsiung J Med Sci; 2020 Jun; 36(6):399-404. PubMed ID: 32003539
[TBL] [Abstract][Full Text] [Related]
30. Upregulation of lncRNA FER1L4 suppresses the proliferation and migration of the hepatocellular carcinoma via regulating PI3K/AKT signal pathway.
Wang X; Dong K; Jin Q; Ma Y; Yin S; Wang S
J Cell Biochem; 2019 Apr; 120(4):6781-6788. PubMed ID: 30382631
[TBL] [Abstract][Full Text] [Related]
31. MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1.
Sun Y; Cao FL; Qu LL; Wang ZM; Liu XY
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1459-1467. PubMed ID: 30840267
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-936 promotes proliferation and invasion of gastric cancer cells by down-regulating FGF2 expression and activating P13K/Akt signaling pathway.
Chen ZF; Wang J; Yu Y; Wei W
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6707-6715. PubMed ID: 32633361
[TBL] [Abstract][Full Text] [Related]
35. AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.
Zheng J; Liu C; Shi J; Wen K; Wang X
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34913077
[TBL] [Abstract][Full Text] [Related]
36. LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.
Lei Y; Wang YH; Wang XF; Bai J
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6315-6323. PubMed ID: 30338799
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of squalene epoxidase linking with PI3K/AKT signaling pathway suppresses endometrial cancer.
Ma L; Huang W; Liang X; Bai G; Wang X; Jiang H; Xin Y; Hu L; Chen X; Liu C
Cancer Sci; 2023 Sep; 114(9):3595-3607. PubMed ID: 37438885
[TBL] [Abstract][Full Text] [Related]
38. SNORD60 promotes the tumorigenesis and progression of endometrial cancer through binding PIK3CA and regulating PI3K/AKT/mTOR signaling pathway.
Wu W; Chen X; Liu X; Bao HJ; Li QH; Xian JY; Lu BF; Zhao Y; Chen S
Mol Carcinog; 2023 Apr; 62(4):413-426. PubMed ID: 36562475
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
40. lncRNA LA16c‑313D11.11 modulates the development of endometrial cancer by binding to and inhibiting microRNA‑205‑5p function and indirectly increasing PTEN activity.
Xin W; Zhao S; Han X; Zhao P; Yu H; Gao X; Li P; Wu Q; Ding J; Hua K
Int J Oncol; 2020 Jul; 57(1):355-363. PubMed ID: 32319598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]